148 related articles for article (PubMed ID: 12627785)
1. Phosphorylcholine-coated stents.
Lewis AL; Stratford PW
J Long Term Eff Med Implants; 2002; 12(4):231-50. PubMed ID: 12627785
[TBL] [Abstract][Full Text] [Related]
2. A Review on Phosphorylcholine-Coated Stents.
Lewis AL; Stratford PW
J Long Term Eff Med Implants; 2017; 27(2-4):233-252. PubMed ID: 29773041
[TBL] [Abstract][Full Text] [Related]
3. Drug loading and elution from a phosphorylcholine polymer-coated coronary stent does not affect long-term stability of the coating in vivo.
Lewis AL; Willis SL; Small SA; Hunt SR; O'byrne V; Stratford PW
Biomed Mater Eng; 2004; 14(4):355-70. PubMed ID: 15472385
[TBL] [Abstract][Full Text] [Related]
4. Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model.
Collingwood R; Gibson L; Sedlik S; Virmani R; Carter AJ
Catheter Cardiovasc Interv; 2005 Jun; 65(2):227-32. PubMed ID: 15900559
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents.
Grube E; Buellesfeld L
Herz; 2004 Mar; 29(2):162-6. PubMed ID: 15054588
[TBL] [Abstract][Full Text] [Related]
6. Coronary artery stents: evaluating new designs for contemporary percutaneous intervention.
Kandzari DE; Tcheng JE; Zidar JP
Catheter Cardiovasc Interv; 2002 Aug; 56(4):562-76. PubMed ID: 12124974
[TBL] [Abstract][Full Text] [Related]
7. A stent is not just a stent: Stent construction and design do matter in its clinical performance.
Lau KW; Johan A; Sigwart U; Hung JS
Singapore Med J; 2004 Jul; 45(7):305-11; quiz 312. PubMed ID: 15221045
[TBL] [Abstract][Full Text] [Related]
8. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
[TBL] [Abstract][Full Text] [Related]
9. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
10. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model.
Huang Y; Liu X; Wang L; Verbeken E; Li S; De Scheerder I
Int J Cardiovasc Intervent; 2003; 5(3):166-71. PubMed ID: 12959735
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylcholine-coated stents in porcine coronary arteries: in vivo assessment of biocompatibility.
Malik N; Gunn J; Shepherd L; Crossman DC; Cumberland DC; Holt CM
J Invasive Cardiol; 2001 Mar; 13(3):193-201. PubMed ID: 11231644
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
[TBL] [Abstract][Full Text] [Related]
13. Role of stent design and coatings on restenosis and thrombosis.
Hara H; Nakamura M; Palmaz JC; Schwartz RS
Adv Drug Deliv Rev; 2006 Jun; 58(3):377-86. PubMed ID: 16650911
[TBL] [Abstract][Full Text] [Related]
14. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results.
Rodriguez AE; Rodriguez Alemparte M; Fernandez Pereira C; Vigo CF; Sampaolesi A; Bernardi V; Marchand E; Tronge J; Palacios IF;
Am Heart J; 2005 Jul; 150(1):188. PubMed ID: 16086559
[TBL] [Abstract][Full Text] [Related]
15. Reduction of subacute stent thrombosis (SAT) using heparin-coated stents in a large-scale, real world registry.
Gupta V; Aravamuthan BR; Baskerville S; Smith SK; Gupta V; Lauer MA; Fischell TA
J Invasive Cardiol; 2004 Jun; 16(6):304-10. PubMed ID: 15155999
[TBL] [Abstract][Full Text] [Related]
16. Silicon-carbide coated coronary stents have low platelet and leukocyte adhesion during platelet activation.
Monnink SH; van Boven AJ; Peels HO; Tigchelaar I; de Kam PJ; Crijns HJ; van Oeveren W
J Investig Med; 1999 Jul; 47(6):304-10. PubMed ID: 10431485
[TBL] [Abstract][Full Text] [Related]
17. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].
Silber S; Herdeg C
Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314
[TBL] [Abstract][Full Text] [Related]
18. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
19. Haemocompatibility of polymer-coated stainless steel stents as compared to uncoated stents.
Mrowietz C; Franke RP; Seyfert UT; Park JW; Jung F
Clin Hemorheol Microcirc; 2005; 32(2):89-103. PubMed ID: 15764818
[TBL] [Abstract][Full Text] [Related]
20. Vascular delivery of c-myc antisense from cationically modified phosphorylcholine coated stents.
Chan KH; Armstrong J; Withers S; Malik N; Cumberland DC; Gunn J; Holt CM
Biomaterials; 2007 Feb; 28(6):1218-24. PubMed ID: 17126396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]